Velarion Records
Free. Unsubscribe any time.

Candel Therapeutics, Inc. (CADL)

Candel Therapeutics, Inc. filed 11 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 5 reporting owners, covering 13 transactions and 459,322 shares. 11 carry the SEC's AFF10B5ONE flag; 0 name a plan only in a footnote. 10 results prints are on file in the same window.

What stands out

Trades in Candel Therapeutics, Inc. 13

Adoption dates in Candel Therapeutics, Inc. 0

Results prints in Candel Therapeutics, Inc. 10

Trades before a print in Candel Therapeutics, Inc. 0

Interval to Candel Therapeutics, Inc.’s next reported results date

How the interval and sources are counted →

Reported results dates on file

A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.

Other companies with plan records

Sources: SEC EDGAR full-text search and the SEC submissions API.